新贛江
873167
雲創數據
835305
辰光醫療
430300
4
杭州高新
300478
5
飛利信
300287
(FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 19.12%43.98億 | 5.63%12.73億 | 27.82%11.37億 | 23.13%10.39億 | 25.97%9.49億 | -18.06%36.92億 | 2.24%12.06億 | -22.27%8.89億 | -27.61%8.44億 | -25.91%7.53億 |
營業收入 | 19.12%43.98億 | 5.63%12.73億 | 27.82%11.37億 | 23.13%10.39億 | 25.97%9.49億 | -18.06%36.92億 | 2.24%12.06億 | -22.27%8.89億 | -27.61%8.44億 | -25.91%7.53億 |
主營業務成本 | 18.91%34.36億 | 6.03%10.01億 | 34.11%8.9億 | 20.12%8.04億 | 20.96%7.4億 | -14.27%28.89億 | -0.84%9.44億 | -22.44%6.64億 | -20.08%6.69億 | -15.57%6.12億 |
毛利 | 19.90%9.63億 | 4.17%2.72億 | 9.32%2.47億 | 34.64%2.36億 | 47.74%2.08億 | -29.30%8.03億 | 15.17%2.61億 | -21.79%2.26億 | -46.75%1.75億 | -51.65%1.41億 |
營業費用 | 15.47%5.16億 | 8.70%1.43億 | 18.81%1.33億 | 19.84%1.26億 | 16.07%1.14億 | 3.85%4.47億 | 20.78%1.32億 | 1.11%1.12億 | -3.70%1.05億 | -3.27%9,831.3萬 |
銷售和管理費用 | 15.47%5.16億 | 8.70%1.43億 | 18.81%1.33億 | 19.84%1.26億 | 16.07%1.14億 | 3.85%4.47億 | 20.78%1.32億 | 1.11%1.12億 | -3.70%1.05億 | -3.27%9,831.3萬 |
營業利潤 | 25.49%4.46億 | -0.45%1.29億 | -0.04%1.14億 | 56.83%1.1億 | 121.00%9,395萬 | -49.55%3.56億 | 9.96%1.29億 | -36.05%1.14億 | -68.12%7,009.2萬 | -77.58%4,251.1萬 |
淨非營業利息收入(費用) | ||||||||||
其他淨收入(費用) | -29.47%-621.6萬 | 294.90%641.6萬 | -123.09%-371萬 | 152.68%70.8萬 | -742.86%-963萬 | 82.86%-480.1萬 | 78.41%-329.2萬 | 70.57%-166.3萬 | 78.47%-134.4萬 | 273.78%149.8萬 |
特殊收入(費用) | -367.66%-877.8萬 | -264.20%-683.6萬 | ---137.3萬 | ---57萬 | ---- | 81.51%-187.7萬 | ---187.7萬 | --0 | --0 | ---- |
-減:勾銷 | 367.66%877.8萬 | 264.20%683.6萬 | --137.3萬 | --57萬 | ---- | -81.51%187.7萬 | --187.7萬 | --0 | --0 | ---- |
其他非經營收入(費用) | 187.62%256.2萬 | 1,036.54%1,325.2萬 | -40.53%-233.7萬 | 195.09%127.8萬 | -742.86%-963萬 | 83.62%-292.4萬 | 72.27%-141.5萬 | 70.57%-166.3萬 | 78.47%-134.4萬 | 273.78%149.8萬 |
稅前利潤 | 25.43%4.4億 | 7.24%1.35億 | -1.86%1.1億 | 60.93%1.11億 | 91.60%8,432萬 | -48.17%3.51億 | 23.12%1.26億 | -34.91%1.12億 | -67.82%6,874.8萬 | -76.69%4,400.9萬 |
所得稅 | 15.98%1.06億 | -6.62%3,245.5萬 | -6.78%2,689.2萬 | 55.52%2,690.9萬 | 86.84%1,998.8萬 | -39.64%9,160.6萬 | 51.69%3,475.6萬 | 4.52%2,884.9萬 | -68.53%1,730.3萬 | -76.88%1,069.8萬 |
除稅後利潤 | 28.78%3.34億 | 12.51%1.03億 | -0.16%8,302萬 | 62.74%8,372.4萬 | 93.13%6,433.2萬 | -50.64%2.59億 | 14.88%9,131.8萬 | -42.45%8,315萬 | -67.58%5,144.5萬 | -76.62%3,331.1萬 |
持續經營利潤 | 28.78%3.34億 | 12.51%1.03億 | -0.16%8,302萬 | 62.74%8,372.4萬 | 93.13%6,433.2萬 | -50.64%2.59億 | 14.88%9,131.8萬 | -42.45%8,315萬 | -67.58%5,144.5萬 | -76.62%3,331.1萬 |
歸屬於少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | 28.78%3.34億 | 12.51%1.03億 | -0.16%8,302萬 | 62.74%8,372.4萬 | 93.13%6,433.2萬 | -50.64%2.59億 | 14.88%9,131.8萬 | -42.45%8,315萬 | -67.58%5,144.5萬 | -76.62%3,331.1萬 |
優先股派息 | ||||||||||
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | 28.78%3.34億 | 12.51%1.03億 | -0.16%8,302萬 | 62.74%8,372.4萬 | 93.13%6,433.2萬 | -50.64%2.59億 | 14.88%9,131.8萬 | -42.45%8,315萬 | -67.58%5,144.5萬 | -76.62%3,331.1萬 |
基本每股收益 | 30.42%10.59 | 14.63%3.29 | 1.92%2.65 | 64.60%2.65 | 94.23%2.02 | -49.63%8.12 | 14.80%2.87 | -42.09%2.6 | -66.67%1.61 | -75.53%1.04 |
稀釋每股收益 | 29.19%10.4 | 13.07%3.2 | 0.39%2.59 | 63.13%2.61 | 92.31%2 | -49.43%8.05 | 14.57%2.83 | -41.89%2.58 | -66.53%1.6 | -75.24%1.04 |
每股派息 | 13.04%1.04 | 13.04%0.26 | 13.04%0.26 | 13.04%0.26 | 13.04%0.26 | 15.00%0.92 | 15.00%0.23 | 15.00%0.23 | 15.00%0.23 | 15.00%0.23 |
貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
審計意見 | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- | -- | -- | -- |